pHL-H1-ccdB-mEF1a-RiH Citations (7)
Originally described in: Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9.Li HL, Fujimoto N, Sasakawa N, Shirai S, Ohkame T, Sakuma T, Tanaka M, Amano N, Watanabe A, Sakurai H, Yamamoto T, Yamanaka S, Hotta A Stem Cell Reports. 2014 Nov 25. pii: S2213-6711(14)00335-X. doi: 10.1016/j.stemcr.2014.10.013. PubMed Journal
Articles Citing pHL-H1-ccdB-mEF1a-RiH
| Articles |
|---|
| Efficient genomic correction methods in human iPS cells using CRISPR-Cas9 system. Li HL, Gee P, Ishida K, Hotta A. Methods. 2015 Oct 23. pii: S1046-2023(15)30133-X. doi: 10.1016/j.ymeth.2015.10.015. PubMed |
| CRISPR Correction of a Homozygous Low-Density Lipoprotein Receptor Mutation in Familial Hypercholesterolemia Induced Pluripotent Stem Cells. Omer L, Hudson EA, Zheng S, Hoying JB, Shan Y, Boyd NL. Hepatol Commun. 2017 Nov;1(9):886-898. doi: 10.1002/hep4.1110. Epub 2017 Oct 16. PubMed |
| Effects of HPV Pseudotype Virus in Cutting E6 Gene Selectively in SiHa Cells. Cheng YX, Chen GT, Yang X, Wang YQ, Hong L. Curr Med Sci. 2018 Apr;38(2):212-221. doi: 10.1007/s11596-018-1868-3. Epub 2018 Apr 30. PubMed |
| A patient-derived iPSC model revealed oxidative stress increases facioscapulohumeral muscular dystrophy-causative DUX4. Sasaki-Honda M, Jonouchi T, Arai M, Hotta A, Mitsuhashi S, Nishino I, Matsuda R, Sakurai H. Hum Mol Genet. 2018 Dec 1;27(23):4024-4035. doi: 10.1093/hmg/ddy293. PubMed |
| In Vitro Modeling of the Bipolar Disorder and Schizophrenia Using Patient-Derived Induced Pluripotent Stem Cells with Copy Number Variations of PCDH15 and RELN. Ishii T, Ishikawa M, Fujimori K, Maeda T, Kushima I, Arioka Y, Mori D, Nakatake Y, Yamagata B, Nio S, Kato TA, Yang N, Wernig M, Kanba S, Mimura M, Ozaki N, Okano H. eNeuro. 2019 Oct 17;6(5). pii: ENEURO.0403-18.2019. doi: 10.1523/ENEURO.0403-18.2019. Print 2019 Sep/Oct. PubMed |
| Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells. Ueda T, Shiina S, Iriguchi S, Terakura S, Kawai Y, Kabai R, Sakamoto S, Watanabe A, Ohara K, Wang B, Xu H, Minagawa A, Hotta A, Woltjen K, Uemura Y, Kodama Y, Seno H, Nakatsura T, Tamada K, Kaneko S. Nat Biomed Eng. 2023 Jan;7(1):24-37. doi: 10.1038/s41551-022-00969-0. Epub 2022 Dec 12. PubMed |
| Establishment of quantitative and consistent in vitro skeletal muscle pathological models of myotonic dystrophy type 1 using patient-derived iPSCs. Kawada R, Jonouchi T, Kagita A, Sato M, Hotta A, Sakurai H. Sci Rep. 2023 Jan 11;13(1):94. doi: 10.1038/s41598-022-26614-z. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.